GILD
Gilead Sciences Inc
150.60$
+0.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5% | 65.1% | 56.1% | 45.6% | 38.0% | 40.7% | 33.1% | 41.7% | 33.3% | 29.5% | 37.7% | 34.0% | |
| 4.2% | 3.4% | 3.8% | 4.9% | 6.5% | 6.3% | 6.0% | 7.5% | 7.7% | 9.9% | 9.6% | 9.4% | |
| 1.4% | 1.2% | 1.3% | 2.4% | 3.8% | 2.8% | 2.6% | 2.3% | 2.3% | 2.8% | 2.9% | 3.0% | |
| -1.0% | -1.9% | 1.6% | 3.3% | 9.1% | -2.1% | 26.5% | 41.7% | 12.9% | – | – | – | |
| -2.1% | 4.6% | 5.1% | 19.6% | -4.2% | -3.6% | -6.6% | 1.8% | -6.5% | -8.5% | -3.1% | -13.4% | |
| 2.2% | 2.3% | 2.5% | 2.3% | 4.2% | 3.7% | 2.6% | 2.1% | 2.7% | 2.2% | 1.8% | 1.9% | |
| -7.3% | -38.2% | -39.4% | -61.6% | 64.9% | -34.8% | -59.2% | -11.5% | -9.0% | -8.4% | -12.0% | -16.3% | |
| 25.6% | 5.7% | 8.1% | 10.5% | 13.4% | 14.4% | 14.0% | 13.2% | 13.6% | 14.0% | 13.6% | 13.6% | |
| -21.5% | -30.6% | -36.2% | -3.7% | -13.1% | -7.8% | -6.4% | -2.0% | -5.1% | -3.7% | -4.0% | -6.5% | |
| 22.9% | 29.7% | 14.0% | 27.5% | -28.2% | -12.2% | 23.0% | -17.4% | -5.5% | -1.0% | 5.2% | -6.1% | |
| -12.2% | -18.0% | -32.0% | 13.0% | -55.7% | -34.0% | 3.1% | -32.5% | -23.7% | -18.9% | -11.9% | -26.3% | |
| 31.8% | 8.7% | -15.2% | -2.5% | 46.8% | -28.1% | -22.8% | -2.4% | 0.3% | 2.5% | 13.6% | -8.2% | |
| 49.3% | 62.8% | 53.6% | 43.3% | 33.8% | 37.1% | 30.5% | 39.6% | 30.6% | 27.4% | 35.8% | 32.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.